Conférences  >  Médecine & Soins de Santé  >  Cancérologie

Kongress- und Kulturmanagement GmbH

Inter- und multidisziplinäre Diagnostik und Therapie im gesamten Bereich der gastrointestinalen Onkologie. Am Vortag: Masterclass für junge Kollegen: Ein Teilbereich der GI Onkologie wird anhand eines Falls von allen Seiten beleuchtet (Vortrag und Diskussion)

Tél.: [01520 3132647];     Email.: davida.drescher@konzeptext.de

Chirurgie,    Radiologie, médecine nucléaire et radiothérapie

Deutsche Gesellschaft für Radioonkologie e.V.

Der DEGRO 2025 richtet sich an Radioonkologen, Medizinphysiker, Strahlenbiologen, MTRAs und Studierende. Unter dem Motto „RADIOONKOLOGIE | TEAMWORK – Maßgeschneidert. Patientenzentriert. Zukunftsorientiert. Selbstbestimmt im Team“ liegt der Fokus auf der interdisziplinären Zusammenarbeit. Abstracts können eingereicht werden. Es werden Refresherkurse sowie Kurse zur Strahlenschutzverordnung angeboten. Weitere Themen: maßgeschneiderte Therapien und patientenzentrierte Ansätze.

Kongressorganisation;     Tél.: [+49 3643 2468-126];     Email.: degro-registrierung@kukm.de

Radioonkologie, Strahlentherapie, Nuklearmedizin, Medizinphysik, Strahlenbiologie, MTRAs, Strahlenschutzverordnung, interdisziplinäre Zusammenarbeit, Abstract-Einreichung, Refresherkurse

Radiologie, médecine nucléaire et radiothérapie,    Cours de radioprotection

Spectus meetings World

We are delighted to extend a warm greeting for the 2nd International Conference on Cancer and Oncology Research, (World Cancer 2025 ) which will be held in the famous city Barcelona, Spain on June 23-24, 2025, organized in coordination with generous support and cooperation from passionate academicians and organizing committee members with the theme “Raising Wings to Promote Cancer Free World".

Tél.: [1 302 308 5943];     Email.: worldcancer@spectusconferences.com

Conference Sessions Tumor heterogeneity and Cancer Metastasis Translational Biology to Medicine in Innovative oncology Immune Responses & DNA Repair - Cancer Fields Cancer Genetics Surgical Oncology Single-cell and Spatial Multiomics in Cancer Research Cancer Prevention & Research Cancer Signaling Next Generation Cancer Models Cancer Imaging Techniques Radiation Oncology Gynecologic Cancer Cancer treatment & palliative care Pediatric Oncology Cancer Immunology & Immunotherapy Breast cancer Computational Analysis of Cancer Nanopore Sequencing of Cancer Genomes Biomarkers in Cancer Organ-Defined Cancers The Application of Clinical Proteomics for Precision Oncology Drug Resistance in Cancer Cancer Genetics and Epigenetics Cancer Diagnostics: From Research to Clinical Practice Advanced Therapies in Cancer Cancer Diagnosis and Screening Cancer Science and Targeted Therapies Cancer Science and Therapeutics Organ Specific Cancer Pharmacology in Cancer AI in Cancer Control Tobacco control Cancer diagnosis and care

The European Association for Cancer Research (EACR)

This virtual conference has become a must-attend for early-career researchers to discuss critical aspects of a scientific career in cancer research. Following the success of the previous edition, the 5th EACR Early-Career Researchers’ Conference will cover the burning questions of young scientists, offering plenty of chances to speak directly with our expert panel and share experiences with peers.

Hannah Barrs (Conference Officer);     Tél.: [N/A];     Email.: hannah.barrs@eacr.org

cancer research, oncology, career advice, guidance from experts, working in academia, working in industry, working in science journalism, early-career researchers, lab leadership, mentoring skills, research funding, open science, science communications, social media in science, translating research, career changes, career development

event lab. GmbH

Anlässlich des 28. Europäischen Hämatologen Kongresses werden bei EHA Kompakt in einer dreistündigen, digitalen Veranstaltung die Neuigkeiten des Kongresses der European Hematology Association anschaulich zusammengefasst. Ziel ist es, einen auf das Wesentliche fokussierten und interessanten Überblick zu den Schwerpunkten der Hämatologie zu geben. Dabei wird insbesondere auf klinisch relevante Innovationen im Fachgebiet gesetzt. Anschließend besteht der Raum für eine angeregte wissenschaftliche Diskussion über die neuen Erkenntnisse. Die Veranstaltung ist Teil der Veranstaltungsreihe "Hämatologie Leipzig" der Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie des Universitätsklinikums Leipzig. Weitere geplante Veranstaltungen unter: https://leipzig-haematologie.de/

Kongressbüro der event lab. GmbH;     Tél.: [+49 341 308884 64];     Email.: haematologie-leipzig@eventlab.org

Onkologie, Zelltherapie, Hämostaseologie, Immunologie, Infektiologie

Hématologie,    Immunologie et Allergie

Uniklinik Köln

After the great success of the 2nd Cologne Conference on Lung Cancer in 2019 we are again looking forward to an exciting meeting on cutting-edge translational research in lung cancer. At the conference, the world's best lung cancer researchers will discuss the current challenges in the diagnosis and treatment of lung cancer. Topics include early detection & prevention of lung cancer, intrinsic & extrinsic influences on tumor evolution, drug resistance & plasticity, next generation immunotherapy, mechanisms of metastasis, tumor-neuronal interactions, liquid biopsies and late breaking clinical trials update.

When: 26 & 27. June 2025

Email.: a.breuer@uni-koeln.de

lungcancer

Fusion

Laura Trundle, Director;     Email.: laura@fusion-conferences.com

DNA Damage Response, cancer biology, replication stress, cancer therapies, PARP inhibitors, BRCA, clinical development

Biologie moléculaire,    Génomique et bio-informatique

ESMO - European Society for Medical Oncology

This important event will bring together leading experts, researchers, and healthcare professionals dedicated to the advancement of gastrointestinal cancers treatment and care. Through groundbreaking presentations, multidisciplinary tumour boards, controversy sessions, and more, attendees will have the opportunity to delve into the latest research findings, innovative therapeutic strategies, and emerging technologies that are shaping the future of GI cancers treatment. The programme will cover a wide spectrum of topics, including molecular prevention, diagnosis, precision therapy, and patient-centered care approaches in the treatment of GI malignancies.

Meetings Operations team;     Tél.: [+41 (0)91 973 19 62];     Email.: GIcongress@esmo.org

molecular prevention, diagnosis, precision therapy, patient-centered care, multidisciplinary tumour boards, immunotherapy, molecular characterisation, early detection, innovative therapeutic strategies, emerging technologies, research methodology, policy and regulation, colorectal cancer, gastric cancer, gastroesophageal junction cancer, hepatocellular carcinoma, biliary tract cancer, pancreatic cancer, oesophageal cancer, anal cancer, neuroendocrine neoplasms

Gastro-entérologie,    Formation médicale continue (FMC)

European Society for Medical Oncology

ESMO TAT, the multi-stakeholder forum gathering key actors in cancer drug development, arrives in one of the most dynamic and best-connected hubs in Asia, making the latest advances in early clinical trials accessible to everyone in the region. Through in-depth discussions on critical topics such as innovation, digital transformation, research methodology, business insights, regulation, and public policy, ESMO TAT Asia aims to drive progress in cancer treatment and research. Located in the lively city of Hong Kong, ESMO TAT Asia promises to be a vibrant gathering with region’s industry, academia, clinicians, and regulators to promote international cooperation and accelerate the anticancer research. Come and join us to chart new paths in cancer drug development in Asia.

ESMO Asia TAT 2025 Secretariat;     Email.: asiacongress@esmo.org

targeted therapies, early drug development, cancer therapeutics, immunotherapy, cytotoxic therapy, cell therapy, biotech, pharmaceutical industry

CHI

Commercializing breakthrough immune-oncology therapeutics is becoming increasingly challenging due to funding limitations, high cost and attrition rates in the clinic, regulatory uncertainties, persistent therapeutic safety and efficacy concerns, and a general lack of understanding of basic biology guiding research in this space. As we develop the 2025 conference program, we are struck by the fact that, despite these challenges, there remains a strong desire to continue to find effective therapeutics for solid tumors. The 13th Annual Immuno-Oncology Summit showcases successes in preclinical and clinical studies grounded in a deep understanding of biology. Coverage spans solid tumor innovations, including bi/multispecific antibodies, antibody-drug conjugates (ADCs), allogenic and in vivo CAR-Ts, TILs, TCRs, Tregs, multiple cell therapies working together, the tumor microenvironment, innate immunity, gamma delta T cells, NK cells, organoid modeling, data science, and machine learning. The program also explores autoimmunity as a critical and complementary area of focus.

Tél.: [781.972.5400];     Email.: chi@healthtech.com

Immunologie et Allergie,    Biotechnologie

Kongress- und Kulturmanagement GmbH

Der Kongress verspricht ein wissenschaftlich anspruchsvolles und interaktives Programm, das sämtliche Aspekte der Schlaganfallversorgung von der prästationären Phase bis zur Rehabilitation umfasst. Besonderen Wert wird daraufgelegt, alle in der Schlaganfallversorgung involvierten Fachdisziplinen zu repräsentieren und die neuesten Entwicklungen in der Schlaganfalltherapie zu präsentieren.

Kongress- und Kulturmanagement GmbH - Frau Svantje Hopf;     Email.: dsg-kongress@kukm.de

CRUK, ESMO, Unicancer

The Molecular Analysis for Precision Oncology Congress 2025 will take place from 15 to 16 September in Paris, France, uniting leading experts in oncology, molecular diagnostics, and precision medicine for dynamic discussions and collaboration, with a focus on decoding the molecular bases of cancer to enable precision oncology. The congress will delve into transformative topics shaping cancer research, including cancer prevention, interception, epigenetics, metastasis, and cancer evolution, offering a deeper understanding of mechanisms driving progression and resistance.

MAP Congress Team;     Tél.: [+41 (0)91 973 19 47];     Email.: map@esmo.org

molecular oncology, precision medicine, molecular diagnostics, cancer prevention, cancer interception, epigenetics, metastasis, cancer evolution, cancer resistance, artificial intelligence in oncology, cancer immunology, immunotherapy, aging and senescence, microbiome and cancer, metabolism dysregulation, therapeutic vulnerabilities, cancer research, oncology collaboration, AI-driven diagnostics, innovative cancer treatments

Pharmacogénétique, Médecine personnalisée,    Médecine translationnelle, essais cliniques

CHI

In its 23rd year Discovery on Target is the premier event highlighting “hot” drug targets and emerging modalities, technologies and strategies for pursuing those targets. The numerous conferences, symposia, courses and training seminars offer key insights for the successful discovery and development of novel therapeutics, from small molecules to biologics to chimeras and conjugates. The 4 day event covers innovations in target identification and lead generation, which includes cancer therapies, protein degradation, induced proximity, AI/machine learning, membrane proteins, translational models, synthetic biology and other relevant topics. New this year is an increased coverage of GLP-1, MASH and obesity, ADCs and bispecifics and on small molecules targeting DNA.

Tél.: [781.972.5400];     Email.: chi@healthtech.com

Biotechnologie,    Pharmacologie et développement des médicaments

The European Association for Cancer Research (EACR)

The 6th edition of this conference will focus on cancer models that span in vitro investigations to in vivo cancer biology. It will emphasise how targeting the mechanisms that control tissue assembly – including the interactions with multiple epithelial cell types and the immune system – affects cancer progression and treatment response. Emerging topics also being discussed include mechanobiology, the immune response, how the extracellular matrix controls cell architecture, and how cell fate transitions underpin tissue morphogenesis and the metastatic cascade. The target audience for this conference is scientists, postdocs, and graduate students interested in the latest generation of engineered ex vivo models of tissue biology, in vivo cancer biology, and the use of these mechanobiological concepts for the development of cancer therapeutics. It will also be highly relevant for industry scientists interested in cutting-edge models of cancer and journal editors interested in ex vivo to in vivo models of biology and cancer.

Conference Officer Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org

cancer research, oncology, in vitro models of cancer, ex vivo models of cancer, in vivo models of cancer, the extracellular matrix, cancer cell architecture, mechanobiology, immune response to cancer, tissue morphogenesis, the metastatic cascade, cancer immunotherapies, advanced imaging technologies, organoids, microtissue platforms, spatial transcriptomics, cell fate transitions, homeostasis, cancer progression, cancer therapeutic developments.

Biologie moléculaire,    Immunologie et Allergie

Nexovo Group

We are thrilled to invite you to the International Research Conference on Nursing & Healthcare, organized by Nexovo Group, set to take place on September 25-26, 2025, in the dynamic city of Dubai, UAE.

Nexovo Nursing 2025 will be a premier event designed to unite professionals, researchers, and thought leaders to delve into the latest developments and innovations in nursing and healthcare.

Tél.: [+91-8688033511];     Email.: Nursing@nexovoconferences.com

Arbeitsgemeinschaft Zervixpathologie und Kolposkopie e.V.

Programmschwerpunkte: • Update Zervixkarzinom-Screening, Kolposkopie – etabliertes diagnostisches Mittel für Zervix, Vulva, Vagina und perianal, Herausforderung Rio-Nomenklatur, Herausforderungen im Abklärungsalgorithmus, Wirkungen und Auswirkungen der HPV-Impfung,

Veranstalter: Frau Britta Eichler;     Email.: sekretariat@ag-cpc.de

Converge Nation

The BioPharma Clinical Trials Nation stands as an exclusive and prestigious conference, accessible only by invitation, uniting prominent clinical trial executives with forward-thinking suppliers and solution providers. The conference content is carefully curated to address crucial clinical trial challenges and interests, stay abreast of pertinent market advancements, and showcase practical and progressive ideas and strategies implemented by successful trailblazers.

Tél.: [041987654321];     Email.: enquiry@convergenation.com

Clinical, Pharmaceutical, Oncology, Cardiology, Clinical Trials

A premier virtual summit uniting researchers, clinicians, policymakers, and advocates to accelerate breakthroughs in cancer prevention, treatment, and survivorship. The conference focuses on innovation, equity, and global collaboration across interdisciplinary themes.

Henry Wood ( Program Chair);     Email.: henrywood@gcareconference.org

Deutsche Gesellschaft für Neuroradiologie e.V. und Österreichische Gesellschaft für Neuroradiologie e.V.

Motto "NEURORADIOLOGIE BESSER MACHEN" = geprägt von Themen, wie der Rolle von wissenschaftlichem und klinischem Fortschritten und Unternehmergeist in der Neuroradiologie, Neuerungen in der Neurotraumatologie, neuen Indikationen und innovativen Techniken in der Neurointervention

Thematische Highlights: Neue Horizonte - the long shot, Neurointerventionen, Neurotraumatologie, Neue Arbeitswelt, Neuroonkologie, Neurodegeneration

Deutsche Gesellschaft für Neuroradiologie e.V. und Kongress- und Kulturmanagement;     Email.: dgnr@neuroradiologie.de und neurorad@kukm.de

Radiologie, médecine nucléaire et radiothérapie,    Neurologie

The European Association for Cancer Research (EACR), with support from The Organisation of European Cancer Institutes (OECI)

This virtual event will explore how meaningful involvement of cancer advocates throughout the research process can lead to impactful cancer research. We will highlight practical examples and offer insights into how researchers, clinicians, and patient advocates can work together to bridge gaps between science and cancer care. Participants will better understand the opportunities and challenges in shaping a collaborative research culture to advance research and improve cancer care.

Chris Iliffe (Conference Officer);     Tél.: [N/A];     Email.: christopher.iliffe@eacr.org

cancer research, oncology, cancer patients, patient perspective, patient advocacy, cancer care, cancer treatment, patient quality of life, cancer symptom management, cancer therapy side effects, innovative therapy development, collaborative research

Médecine translationnelle, essais cliniques,    Génie biomédical

event lab. GmbH

Im Herzen des Ruhrgebiets vereinen wir die Expertise von sieben kinderchirurgischen Fachabteilungen, um einen praxisnahen und innovativen Austausch auf höchstem Niveau zu fördern. Unser Konsortium spiegelt die Vielfalt und Stärke der kinderchirurgischen Versorgung wider – von universitären Spitzenzentren bis hin zu renommierten Lehrkrankenhäusern. Wir freuen uns darauf, Sie an einem zentralen Veranstaltungsort begrüßen zu dürfen, um gemeinsam die Zukunft der Kinderchirurgie zu gestalten und weiter voranzutreiben.

Tabea Just, event lab. GmbH;     Tél.: [+49 341 30 88 84 67];     Email.: akic@eventlab.org

Kinderchirurgie, Pädiatrie, Chirurgie, Kinderarzt, Kinderärzte, Urologie, Gynäkologie, Onkologie, Neonatologie, Austausch, Fortbildung, Austausch

Pédiatrie, Néonatalogie,    Gynécologie/obstétrique

The European Association for Cancer Research (EACR) and The Mark Foundation for Cancer Research

Early-onset cancers are rising globally. Cancers typically associated with those over the age of 50 are increasingly being diagnosed in young adults. How to prevent and treat these tumours is still unknown. This conference aims to foster a deeper understanding of the biological mechanisms, risk factors, and clinical implications of early-onset cancers. By bringing together leading experts from diverse fields in cancer research, the meeting will provide a unique platform to discuss the latest discoveries about early-onset cancers, promoting interdisciplinary collaboration and identifying strategies for early detection, prevention, and treatment. Special attention will be given to knowledge gaps, translational studies and healthcare disparities, and towards improving the clinical management of early-onset cancer patients. The target audience for this conference is researchers and physicians who are interested in the epidemiology and aetiology of sporadic cancers among younger adults to discuss key questions in the field and lay the foundations for generating a community dedicated to the study of early-onset cancers.

Conference Officer, Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org

cancer research, oncology, early-onset cancers, biological mechanisms of cancer, cancer risk factors, clinical implications, early detection, prevention, cancer treatment, cancer therapies, healthcare disparities, translational cancer research, clinical management of cancer patients, cancer epidemiology, cancer aetiology, molecular pathology, exposome changes, cancer microbiome, cancer immunity, the tumour microenvironment, carcinogenesis, cancer epigenetics, preclinical experimental models, microsimulation modelling, cancer, cancer survivorship.

Biologie moléculaire,    Biologie des systèmes

EMBL Heidelberg

This meeting will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. We aim to bring together scientists from across several disciplines connected with cancer research, for a unique opportunity to interact and stimulate further integration of these efforts.

EMBL Events;     Email.: events@embl.de

Mathews International LLC

The International Cancer Science and Research Conference 2025 scheduled for November 17-19, 2025, in Singapore, promises to be a pivotal event in the field of oncology. Held under the theme "Revolutionizing Cancer Care: Innovations and Collaborations for a Healthier Future," this hybrid event will welcome both onsite and virtual attendees, ensuring global accessibility. As one of the most anticipated Cancer Conferences of the year, it will unite leading oncologists, researchers, and healthcare professionals to advance the fight against cancer. This Oncology Conference will highlight ground breaking advancements in cancer prevention, diagnostics, and treatment, with key discussions focusing on areas such as immunotherapy, precision medicine, and targeted therapies. Participants in the Cancer Conferences 2025 will have the chance to share insights, foster collaborations, and explore innovative approaches to improving patient outcomes. Don’t miss this unparalleled opportunity to contribute to the future of cancer care—register now!

Tél.: [+13124624448];     Email.: cancer@mathewsconference.com

Cancer Conferences, Cancer Conferences 2025, Cancer Science and Research Conference, Oncology Conference, Radiology Conference, Oncology Conferences, Radiology Conferences, Oncology Events, Cancer Events, Oncology Conferences 2025, Cancer Congress, Cancer Hybrid Events, Cancer Webinars, Cancer Seminars, Cancer Meetings, Cancer Workshops, Cancer Virtual Conference, Cancer Symposium, Cancer Online Event, Cancer Hybrid Event, Cancer Summit, Cancer Expo, Upcoming Cancer Conference, International Cancer Conferences, Global Cancer Congress, Cancer Hybrid Webinar, Cancer Hybrid Seminar, International Conference on Cancer, Global Congress on Cancer, International Summit on Cancer, Cancer Seminar, Cancer Meeting, Cancer Workshop, Upcoming Cancer Congress, Upcoming Cancer Event, Cancer Event, Cancer Conference in USA, Cancer Congress in Europe, Cancer Meeting in Italy, Cancer Seminar in UK, Cancer Event in London, Cancer Workshop in Spain, Cancer Hybrid Event in Paris, Cancer Virtual conference in France, Top Cancer Conference, Top 10 Cancer Symposiums

The European Association for Cancer Research (EACR)

This conference will explore the fundamental mechanisms controlling cancer cell plasticity at multiple biological levels including the epigenome, transcriptome, metabolome, and cellular microenvironment. Our panel of expert speakers will also discuss innovative approaches to target cell plasticity using novel pharmacological interventions that aim to prevent or reverse the adaptive mechanisms cancer cells use to circumvent conventional therapies.

Chris Iliffe (Conference Officer);     Tél.: [N/A];     Email.: christopher.iliffe@eacr.org

cancer research, oncology, cancer cell biology, cancer cell plasticity, cancer epigenetics, cellular microenvironment, tumour microenvironment, tumour heterogeneity, cancer transcriptomics, metabolic reprogramming in cancer, phenotypic changes in cancer, cancer progression, cancer therapy resistance, virtual academic conference

Biologie moléculaire,    Médecine translationnelle, essais cliniques